Sage Journals: Discover world-class research

Open access

Research article

First published 2025

TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2− breast cancer

Heather L. McArthur, Sara M. Tolaney, Rebecca Dent [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2025

Capivasertib/Fulvestrant in patients with HR+,HER2-low or HER2-negative locally advanced or metastatic breast cancer

Karam Aboud, Magda Meissner, Rob Jones

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysis

Dionisia Quiroga, Charles Pei, Julie A. Stephens [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2026

Predictive Value of Magee Equation 3 for Tumor and Axillary Response to Neoadjuvant Chemotherapy in HR-Positive,HER2-Negative Breast Cancer

Mustafa Onur Beştaş, Erkan Güler, Ahmet Dağ [...]

The American Surgeon™

Retricted access

Research article

First published 2023-4

Comparison of clinicopathological characteristics and response to neoadjuvant systemic therapy in patients with HER2-low-positive and HER2-zero breast cancer

Wenjie Shi, Xinyu Wan, Jinzhi He [...]

Journal of Investigative Medicine

Open access

Research article

First published 2019

An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)

Emanuela Risi, Chiara Biagioni, Matteo Benelli [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

The association between HER2-low expression and prognosis of breast cancer: a systematic review and meta-analysis

Yuyao Tang, Guoshuang Shen, Yuanfang Xin [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2021-03

Histone Deacetylase 7 Gene Overexpression Is Associated with Poor Prognosis of Triple-Negative Breast Cancer Patients

Bojana Uzelac, Ana Krivokuca, Snezana Susnjar [...]

Genetic Testing and Molecular Biomarkers

Open access

Research article

First published 2023

Clinicopathologic Features and Prognosis of Female Early Breast Cancer With HER2 Low Expression: A Propensity Score Matched Analysis

Lanyi Dai, Qiyuan Huang, Rong Guo [...]

Clinical Medicine Insights: Oncology

Open access

Review article

First published 2022

Oncotype DX Recurrence Score in premenopausal women

Shiliang Zhang, Kasey C. Fitzsimmons, Sara A. Hurvitz

Therapeutic Advances in Medical Oncology

Search results